Engineered DNA-encoded PCSK9 inhibitors may provide an effective alternative for treating high cholesterol
Researchers have developed novel synthetic DNA-encoded monoclonal antibodies (DMAbs) directed against PCSK9, a protein key to regulating cholesterol levels in the bloodstream. Results of preclinical s..